These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx? Zou Y; Meng F; Deng C; Zhong Z J Control Release; 2016 Oct; 239():149-58. PubMed ID: 27569664 [TBL] [Abstract][Full Text] [Related]
3. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy. Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309 [TBL] [Abstract][Full Text] [Related]
4. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo. Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307 [TBL] [Abstract][Full Text] [Related]
5. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment. Zou Y; Xia Y; Meng F; Zhang J; Zhong Z Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299 [TBL] [Abstract][Full Text] [Related]
6. Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(ε-caprolactone) micelles. Fang Y; Jiang Y; Zou Y; Meng F; Zhang J; Deng C; Sun H; Zhong Z Acta Biomater; 2017 Mar; 50():396-406. PubMed ID: 28065871 [TBL] [Abstract][Full Text] [Related]
7. Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma. Dai W; Yang T; Wang Y; Wang X; Wang J; Zhang X; Zhang Q Nanomedicine; 2012 Oct; 8(7):1152-61. PubMed ID: 22306158 [TBL] [Abstract][Full Text] [Related]
8. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo. Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618 [TBL] [Abstract][Full Text] [Related]
9. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo. Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807 [TBL] [Abstract][Full Text] [Related]
10. Angiopep-2-conjugated poly(ethylene glycol)- Lu F; Pang Z; Zhao J; Jin K; Li H; Pang Q; Zhang L; Pang Z Int J Nanomedicine; 2017; 12():2117-2127. PubMed ID: 28356732 [TBL] [Abstract][Full Text] [Related]
11. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials. Sun B; Deng C; Meng F; Zhang J; Zhong Z Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338 [TBL] [Abstract][Full Text] [Related]
12. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo. Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765 [TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
14. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma. Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid derivative-based self-assembled nanoparticles for the treatment of melanoma. Jin YJ; Termsarasab U; Ko SH; Shim JS; Chong S; Chung SJ; Shim CK; Cho HJ; Kim DD Pharm Res; 2012 Dec; 29(12):3443-54. PubMed ID: 22886625 [TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD-Functionalized and Disulfide-Crosslinked Iodine-Rich Polymersomes as a Robust and Smart Theranostic Agent for Targeted CT Imaging and Chemotherapy of Tumor. Zou Y; Wei Y; Sun Y; Bao J; Yao F; Li Z; Meng F; Hu C; Storm G; Zhong Z Theranostics; 2019; 9(26):8061-8072. PubMed ID: 31754381 [TBL] [Abstract][Full Text] [Related]
17. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829 [TBL] [Abstract][Full Text] [Related]
18. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684 [TBL] [Abstract][Full Text] [Related]
19. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes. Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516 [TBL] [Abstract][Full Text] [Related]
20. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Xiong XB; Ma Z; Lai R; Lavasanifar A Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]